PRKCB and diabetes mellitus: First, STZ-DM mice exhibited increased PKCβ activation and increased degradation of GLP-1 receptor (GLP-1R) via ubiquitination, enhanced phospho-c-Raf(ser338), and enhanced angiotensin II activation of phospho-Erk1/2 (79).